Stocks and Investing
Stocks and Investing
Tue, March 5, 2024
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
Joseph Pantginis Reiterated (ATXS) at Strong Buy and Held Target at $18 on, Mar 5th, 2024
Joseph Pantginis of HC Wainwright & Co., Reiterated "Astria Therapeutics, Inc." (ATXS) at Strong Buy and Held Target at $18 on, Mar 5th, 2024.
Joseph has made no other calls on ATXS in the last 4 months.
There is 1 other peer that has a rating on ATXS. Out of the 1 peers that are also analyzing ATXS, 0 agree with Joseph's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joseph
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $25 on, Wednesday, November 15th, 2023
Contributing Sources